Author: Tominaga T.
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.21, Iss.11, 2001-11, pp. : 775-782
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tamoxifen plus chemotherapy worth it in early breast cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 354, 2002-01 ,pp. :
Should Tamoxifen Be Used in Breast Cancer Prevention?
Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. :
Tamoxifen plus chemotherapy worth it in early breast cancer?
Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. :
Tamoxifen for breast cancer prophylaxis: where to from here?
Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. :
Is There a Growing Role for Endocrine Therapy in the Treatment of Breast Cancer?
By Lønning P.E.
Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. :